Vitamin D3 intake as modulator for the early biomarkers of myocardial tissue injury in diabetic hyperlipidaemic rats

References

• Abenavoli, L., et al., 2016. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World journal of gastroenterology, 22 (31), 7006–7016.
   PubMed Web of Science ®Google Scholar
• Aktay, G., et al., 2019. Protective effect of atorvastatin on oxidative stress in streptozotocin-induced diabetic rats independently their lipid-lowering effects. Journal of biochemical and molecular toxicology, 33, e22295.
   PubMed Web of Science ®Google Scholar
• Aleksova, A., et al., 2015. Vitamin D deficiency in patients with acute myocardial infarction: an Italian single-center study. International journal for vitamin and nutrition research, 85, 23–30.
   PubMed Web of Science ®Google Scholar
• Aljabri, K.S., Bokhari, S.A., and Khan, M.J., 2010. Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency. Annals of Saudi medicine, 30 (6), 454–458.
   PubMed Web of Science ®Google Scholar
• Anderson, J.L., et al., 2007. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non St-elevation myocardial infarction. Circulation, 116 (7), e148–e304.
   PubMed Web of Science ®Google Scholar
• Balon, T.W., and Nadler, J.L., 1997. Evidence that nitric oxide increases glucose transport in skeletal muscle. Journal of applied physiology, 82 (1), 359–363.
   PubMed Web of Science ®Google Scholar
• Bellomo, E.A., Meur G., and Rutter, G.A., 2011. Glucose regulates free cytosolic Zn2+ concentration, Slc39 (ZiP), and metallothionein gene expression in primary pancreatic islet β-Cells. Journal of biological chemistry, 286, 25778–25789.
   PubMed Web of Science ®Google Scholar
• Ben Salem, M., et al., 2017. Protective effects of Cynara scolymus leaves extract on metabolic disorders and oxidative stress in alloxan-diabetic rats. BMC complementary and alternative medicine, 17 (1), 328.
   PubMed Web of Science ®Google Scholar
• Beysel, S., et al., 2017. Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease. Clinical interventions in aging, 12, 2063–2068.
   PubMed Web of Science ®Google Scholar
• Bodde, M.C., et al., 2018. A rapid (differential) effect of rosuvastatin and atorvastatin on high-sensitivity cardiac Troponin-I in subjects with stable cardiovascular disease. Clinical pharmacology and therapeutics, 104, 311–316.
   PubMed Web of Science ®Google Scholar
• Brun, J.F., et al., 1995. Effects of oral zinc gluconate on glucose effectiveness and insulin sensitivity in humans. Biological trace element research, 47 (1–3), 385–391.
   PubMed Web of Science ®Google Scholar
• Carlberg, C., 2019. Nutrigenomics of Vitamin D. Nutrients, 11 (3), pii:E676.
   Web of Science ®Google Scholar
• Cefalu, W.T., 2001. Insulin resistance: cellular and clinical concepts. Experimental biology and medicine, 226 (1), 13–26.
   Web of Science ®Google Scholar
• Cernacek, P. and Stewart, D.J., 1989. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochemical and biophysical research communications, 161 (2), 562–567.
   PubMed Web of Science ®Google Scholar
• Christakos, S., et al., 2003. Vitamin D target proteins: function and regulation. Journal of cellular biochemistry,88, 238–244.
   PubMed Web of Science ®Google Scholar
• Christensen, R., et al., 2009. Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obesity reviews,10, 475–486.
   PubMed Web of Science ®Google Scholar
• Coventry, L.L., Finn, J., and Bremner, A.P., 2011. Sex differences in symptom presentation in acute myocardial infarction: a systematic review and meta-analysis. Heart and lung, 40, 477–491.
   PubMed Web of Science ®Google Scholar
• Das, U.N., 2016. Heart-type fatty acid-binding protein (H-FABP) and coronary heart disease. Indian heart journal, 68 (1), 16–18.
   PubMedGoogle Scholar
• De Metrio, M., et al., 2015. Vitamin D plasma levels and In-Hospital and 1-Year outcomes in acute coronary syndromes: a prospective study. Medicine (Baltimore),94, e857.
   PubMed Web of Science ®Google Scholar
• Duplancic, D., et al., 2013. The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection. Clinical interventions in aging, 8, 149–156.
   PubMed Web of Science ®Google Scholar
• Dusso, A.S., Brown, A.J., and Slatopolsky, E., 2005. Vitamin D. American journal of physiology. renal physiology, 289 (1), F8–F28.
   PubMed Web of Science ®Google Scholar
• Elseweidy, M.M., et al., 2017. Vitamin D3 intake as regulator of insulin degrading enzyme and insulin receptor phosphorylation in diabetic rats. Biomedicine and pharmacotherapy, 85, 155–159.
   PubMed Web of Science ®Google Scholar
• Elseweidy, M.M., et al., 2016. Policosanol as a new inhibitor candidate for vascular calcification in diabetic hyperlipidemic rats. Experimental biology and medicine, 241 (17), 1943–1949.
   PubMed Web of Science ®Google Scholar
• Farhangi, M.A., et al., 2017a. The effects of vitamin D administration on brain inflammatory markers in high fat diet induced obese rats. BMC neuroscience, 18 (1), 81.
   PubMed Web of Science ®Google Scholar
• Farhangi, M.A., et al., 2017b. Cardiac tissue oxidative stress and inflammation after vitamin D administrations in high fat- diet induced obese rats. BMC cardiovascular disorders, 17 (1), 161.
   PubMed Web of Science ®Google Scholar
• Faure, P., et al., 1992. Zinc and insulin sensitivity. Biological trace element research, 32, 305–310.
   PubMed Web of Science ®Google Scholar
• Federico, G., et al., 2018. Vitamin D status, enterovirus infection, and type 1 diabetes in Italian children/adolescents. Pediatric diabetes, 19, 923–929.
   PubMed Web of Science ®Google Scholar
• Feron, O., et al., 2001. Hydroxy-methylglutaryl-coenzyme a reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. Circulation, 103 (1), 113–118.
   PubMed Web of Science ®Google Scholar
• Ferreira-González, I., 2014. The epidemiology of coronary heart disease. Revista Española de Cardiología, 67 (2), 139–144.
   PubMed Web of Science ®Google Scholar
• Ghosh, A., et al., 2017. Role of free fatty acids in endothelial dysfunction. Journal of biomedical science, 24 (1), 50.
   PubMed Web of Science ®Google Scholar
• Glatz, J.F. and Van Der Vusse, G.J., 1989. Intracellular transport of lipids. Molecular and cellular biochemistry, 88 (1-2), 37–44.
   PubMed Web of Science ®Google Scholar
• Grammatiki, M., Karras, S., and Kotsa, K., 2019. The role of vitamin D in the pathogenesis and treatment of diabetes mellitus: a narrative review. Hormones, 18 (1), 37–48.
   PubMedGoogle Scholar
• Gregoriou, E., et al., 2017. The effects of vitamin d supplementation in newly diagnosed type 1 diabetes patients: systematic review of randomized controlled trials. The review of diabetic studies, 14 (2-3), 260–268.
   PubMedGoogle Scholar
• Gruzdeva, O., et al., 2016. Early effects of treatment low-dose atorvastatin on markers of insulin resistance and inflammation in patients with myocardial infarction. Frontiers in pharmacology, 7, 324.
   PubMed Web of Science ®Google Scholar
• Guadarrama-Lopez, A.L., Valdes-Ramos, R., and Martinez-Carrillo, B.E., 2014. Type 2 diabetes, PUFAs, and vitamin D: their relation to inflammation. Journal of immunology research, 2014, 860703.
   PubMed Web of Science ®Google Scholar
• Hafez, M., et al., 2017. Vitamin D status in Egyptian children with type 1 diabetes and the role of vitamin D replacement in glycemic control. Journal of pediatric endocrinology and metabolism, 30 (4), 389–394.
   PubMed Web of Science ®Google Scholar
• Hafez, M., et al., 2019. Effect of Vitamin D supplementation on lipid profile in vitamin D-deficient children with type 1 diabetes and dyslipidemia. Hormone research in paediatrics, 91 (5), 311–318.
   PubMed Web of Science ®Google Scholar
• Han, Q., et al., 2018. Dysregulation of cardiac lipid parameters in high-fat high-cholesterol diet-induced rat model. Lipids in health and disease, 17 (1), 255.
   PubMed Web of Science ®Google Scholar
• Hedblad, B., et al., 2002. Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabetic medicine, 19 (6), 470–475.
   PubMed Web of Science ®Google Scholar
• Hisada, T., et al., 2012. Statin inhibits hypoxia-induced endothelin-1 via accelerated degradation of HIF-1α in vascular smooth muscle cells. Cardiovascular research, 95 (2), 251–259.
   PubMed Web of Science ®Google Scholar
• Huang, Y., et al., 2013. Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: a cross-sectional epidemiological study. Cardiovascular diabetology, 12 (1), 17.
   PubMed Web of Science ®Google Scholar
• Iqbal, S., Khan, S., and Naseem, I., 2018. Antioxidant role of vitamin d in mice with alloxan-induced diabetes. Canadian journal of diabetes, 42 (4), 412–418.
   PubMed Web of Science ®Google Scholar
• Jafari, T., Fallah, A.A., and Barani, A., 2016. Effects of vitamin D on serum lipid profile in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Clinical nutrition, 35 (6), 1259–1268.
   PubMed Web of Science ®Google Scholar
• Kechrid, Z., et al., 2012. Vitamin D supplementation modulates blood and tissue zinc, liver glutathione and blood biochemical parameters in diabetic rats on a zinc-deficient diet. Biological trace element research, 148 (3), 371–377.
   PubMed Web of Science ®Google Scholar
• Khan, S.Q., et al., 2007. C-terminal pro–endothelin-1 offers additional prognostic information in patients after acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) Study. American heart journal, 154 (4), 736–742.
   PubMed Web of Science ®Google Scholar
• Kureishi, Y., et al., 2000. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nature medicine, 6 (9), 1004–1010.
   PubMed Web of Science ®Google Scholar
• Kurihara, H., et al., 1989. Endothelin: a potent vasoconstrictor associated with coronary vasospasm. Life sciences, 44 (25), 1937–1943.
   PubMed Web of Science ®Google Scholar
• Laufs, U. and Liao, J.K., 1998. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA Stability by Rho GTPase. Journal of biological chemistry, 273, 24266–24271.
   PubMed Web of Science ®Google Scholar
• Lazarte, J. and Hegele, R.A., 2019. Dyslipidemia management in adults with diabetes. Canadian journal of diabetes, pii:S1499-2671(19)30373-9. doi:https://doi.org/10.1016/j.jcjd.2019.07.003
   Google Scholar
• Le Roith, D. and Zick, Y., 2001. Recent advances in our understanding of insulin action and insulin resistance. Diabetes care, 24 (3), 588–597.
   PubMed Web of Science ®Google Scholar
• Lefebvre, P., et al., 2006. Sorting out the roles of PPARα in energy metabolism and vascular homeostasis. Journal of clinical investigation, 116 (3), 571–580.
   PubMed Web of Science ®Google Scholar
• Lennen, R.M. and Pfleger, B.F., 2013. Modulating membrane composition alters free fatty acid tolerance in escherichia coli. PLoS One, 8 (1), e54031.
   PubMed Web of Science ®Google Scholar
• Mangaloglu, L., et al., 2002. Treatment with atorvastatin ameliorates hepatic very low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity. Metabolism–metabolism, 51, 409–418.
   PubMed Web of Science ®Google Scholar
• Mcfarlane, S.I., et al., 2002. Pleiotropic effects of statins: lipid reduction and beyond. The journal of clinical endocrinology and metabolism, 87, 1451–1458.
   PubMed Web of Science ®Google Scholar
• Meerza, D., Naseem, I., and Ahmed, J., 2012. Effect of 1, 25(OH)2 vitamin D3 on glucose homeostasis and DNA damage in type 2 diabetic mice. Journal of diabetes and its complications, 26 (5), 363–368.
   PubMed Web of Science ®Google Scholar
• Mehta, P.K., Wei, J., and Wenger, N.K., 2015. Ischemic heart disease in women: a focus on risk factors. Trends in cardiovascular medicine, 25 (2), 140–151.
   PubMed Web of Science ®Google Scholar
• Mendis, S., et al., 2011. Global atlas on cardiovascular disease prevention and control. edited by Shanthi Mendis. Geneva: World Health Organization.
   Google Scholar
• Mohamad, M.I., El-Sherbeny, E.E., and Bekhet, M.M., 2016. The effect of vitamin d supplementation on glycemic control and lipid profile in patients with type 2 diabetes mellitus. Journal of the American college of nutrition, 35 (5), 399–404.
   PubMed Web of Science ®Google Scholar
• Ning, C., et al., 2015. Lipid metabolism and inflammation modulated by Vitamin D in liver of diabetic rats. Lipids in health and disease, 14, 31
   PubMed Web of Science ®Google Scholar
• O’gara, P.T., et al., 2013. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. Journal of the American college of cardiology, 127, e362–e425.
   Google Scholar
• Odegaard, J.I. and Chawla, A., 2013. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science, 339, 172–177.
   PubMed Web of Science ®Google Scholar
• Oliver, M.F., 2006. Sudden cardiac death: the lost fatty acid hypothesis. QJM, 99 (10), 701–709.
   PubMed Web of Science ®Google Scholar
• Öztaş, E., et al., 2019. Gliclazide alone or in combination with atorvastatin ameliorated reproductive damage in streptozotocin-induced type 2 diabetic male rats. Saudi pharmaceutical journal, 27 (3), 422–431.
   PubMed Web of Science ®Google Scholar
• Park, K.C., et al., 2017. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovascular research, 113 (14), 1708–1718.
   PubMed Web of Science ®Google Scholar
• Patten, R.D. and Hall-Porter, M.R., 2009. Small animal models of heart failure. Cardiovascular research, 2, 138–144.
   Google Scholar
• Plenge, J.K., et al., 2002. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation, 106 (12), 1447–1452.
   PubMed Web of Science ®Google Scholar
• Qinna, N.A. and Badwan, A.A., 2015. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Drug design, development and therapy, 9, 2515–2525.
   PubMed Web of Science ®Google Scholar
• Rak, K. and Bronkowska, M., 2018. Immunomodulatory effect of Vitamin D and its potential role in the prevention and treatment of Type 1 diabetes Mellitus-A narrative review. Molecules, 24 (1), pii:E53.
   Web of Science ®Google Scholar
• Reichert, K., et al., 2016. Atorvastatin improves ventricular remodeling after myocardial infarction by interfering with collagen metabolism. PLoS One, 11 (11), e0166845.
   PubMed Web of Science ®Google Scholar
• Rewers, M., et al., 2004. Insulin sensitivity, insulinemia, and coronary artery disease. Diabetes care, 27, 781–787.
   PubMed Web of Science ®Google Scholar
• Rice, B.H., et al., 2011. Dairy components and risk factors for cardiometabolic syndrome: recent evidence and opportunities for future research. Advances in nutrition, 2 (5), 396–407.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Calvo, R., et al., 2009. Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A. Hepatology,49, 106–115.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Magana, M.P., et al., 2019. Hypoglycemic activity of Tilia Americana, Borago officinalis, Chenopodium nuttalliae, and Piper sanctum on Wistar Rats. Journal of Diabetes Research, 2019, 7836820.
   PubMed Web of Science ®Google Scholar
• Seo, W.K., et al., 2017. Free fatty acid is associated with thrombogenicity in cardioembolic stroke. Cerebrovascular diseases, 44 (3–4), 160–168.
   PubMed Web of Science ®Google Scholar
• Shah, N.A. and Khan, M.R., 2014. Antidiabetic effect of sida cordata in alloxan induced diabetic rats %J. BioMed research international, 2014, 1–15.
   Web of Science ®Google Scholar
• Smith, S.C., et al., 2006. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 Update. Circulation, 113, 2363–2372.
   PubMed Web of Science ®Google Scholar
• Stanley, W.C., Recchia, F.A., and Lopaschuk, G.D., 2005. Myocardial substrate metabolism in the normal and failing heart. Physiological reviews, 85 (3), 1093–1129.
   PubMed Web of Science ®Google Scholar
• Steg, P.G., et al., 2012. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). European heart journal, 33, 2569–2619.
   PubMed Web of Science ®Google Scholar
• Tamilselvan, B., Seshadri, K., and Venkatraman, G., 2013. Role of vitamin D on the expression of glucose transporters in L6 myotubes. Indian journal of endocrinology and metabolism, 17, 326–328.
   PubMedGoogle Scholar
• Thygesen, K., et al., 2010. Recommendations for the use of cardiac troponin measurement in acute cardiac care. European heart journal, 31 (18), 2197–2204.
   PubMed Web of Science ®Google Scholar
• Trifunovic, D., et al., 2014. Acute insulin resistance in ST-segment elevation myocardial infarction in non-diabetic patients is associated with incomplete myocardial reperfusion and impaired coronary microcirculatory function. Cardiovascular diabetology, 13 (1), 73.
   PubMed Web of Science ®Google Scholar
• Van De Sluis, B., Wijers, M., and Herz, J., 2017. News on the molecular regulation and function of hepatic low-density lipoprotein receptor and LDLR-related protein 1. Current opinion in lipidology,28, 241–247.
   PubMed Web of Science ®Google Scholar
• Van Stee, M.F., De Graaf, A.A., and Groen, A.K., 2018. Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. Cardiovascular diabetology, 17 (1), 94.
   PubMed Web of Science ®Google Scholar
• Vupputuri, A., et al., 2015. Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain. Indian heart journal, 67 (6), 538–542.
   PubMedGoogle Scholar
• Xu, L.-Q., et al., 2018. Early diagnostic performance of heart-type fatty acid binding protein in suspected acute myocardial infarction: evidence from a meta-analysis of contemporary studies. Heart, lung and circulation, 27 (4), 503–512.
   PubMed Web of Science ®Google Scholar
• Yanagisawa, M., et al., 1988. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332 (6163), 411–415.
   PubMed Web of Science ®Google Scholar
• Yang, W., et al., 2017. Effects of the duration of hyperlipidemia on cerebral lipids, vessels and neurons in rats. Lipids in health and disease, 16 (1), 26.
   PubMed Web of Science ®Google Scholar